<DOC>
	<DOCNO>NCT02973048</DOCNO>
	<brief_summary>Over past 15 year , cesarean delivery commonly perform spinal anesthesia use hyperbaric bupivacaine provide adequate sensory motor block . Despite effective surgical anesthesia , bupivacaine associate long duration motor block dose-dependent maternal hypotension potentially harmful fetus . Prilocaine new 2 % hyperbaric formulation ( HP ) , develop recently , show rapid onset action faster regression motor block compare local anesthetic without noteworthy side-effects use intrathecally . The aim randomize , multicenter , power clinical trial investigate whether HP may efficient alternative hyperbaric bupivacaine schedule caesarean delivery spinal anesthesia .</brief_summary>
	<brief_title>Hyperbaric Bupivacaine Versus Hyperbaric Prilocaine 2 % Cesarean Section Under Spinal Anesthesia</brief_title>
	<detailed_description />
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Prilocaine</mesh_term>
	<criteria>Inclusion Criteria : American Society Anesthesiologists physical status ( ASA ) &lt; III Age 1840 year Body Weight &lt; 110 kg Height 160 175 cm Gestational age &gt; 37 SA Elective cesarean delivery Singleton pregnancy Non complicate pregnancy Signed inform consent obtain prior study specific assessment procedure Twin pregnancy History 2 cesarean section Diabetes gestational diabetes Placenta praevia Congenital foetale abnormality Intrauterine growth retardation Patient labour Membrane rupture Known allergy local anaesthetic Standard contraindication neuraxial block . Disagreement patient Neurological impairment Gestational low blood pressure Pre eclampsia eclampsia</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Cesarean delivery</keyword>
	<keyword>Spinal anesthesia</keyword>
	<keyword>Local anesthetic</keyword>
</DOC>